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Abstract: Cytochrome P450 17A1 (CYP17A1) is an important drug target for 
castration resistant prostate cancer. It is a bi-functional enzyme, catalyzing 
production of glucocorticoid precursors by hydroxylation of pregnene-nucleus, 
and androgen biosynthesis by a second C C lyase step, at the expense of 
glucocorticoid production. Cytochrome b5 (cyt b5) is known to be a key 
regulator of the androgen synthesis reaction in vivo, by a mechanism that is 
not well understood. Two hypotheses have been proposed for the mechanism 
by which cyt b5 increases androgen biosynthesis. Cyt b5 could act as an 
allosteric effector, binding to CYP17A1 and either changing its selective 
substrate affinity or altering the conformation of the P450 to increase the 
catalytic rate or decrease unproductive uncoupling channels. Alternatively, cyt 
b5 could act as a redox donor for supply of the second electron in the P450 
cycle, reducing the oxyferrous complex to form the reactive peroxo-
intermediate. To understand the mechanism of lyase enhancement by cyt b5, 
we generated a redox-inactive form of cyt b5, in which the heme is replaced 
with a Manganese-protoporphyrin IX (Mn-b5), and investigated enhancement 
of androgen producing lyase reaction by CYP17A1. Given the critical 
significance of a stable membrane anchor for all of the proteins involved and 
the need for controlled stoichiometric ratios, we employed the Nanodisc 
system for this study. The redox inactive form was observed to have no effect 
on the lyase reaction, while reactions with the normal heme-iron containing 
cyt b5 were enhanced ∼5 fold as compared to reactions in the absence of cyt 
b5. We also performed resonance Raman measurements on ferric CYP17A1 
bound to Mn-b5. Upon addition of Mn-b5 to Nanodisc reconstituted CYP17A1, 
we observed clear evidence for the formation of a b5-CYP17A1 complex, as 
noted by changes in the porphyrin modes and alteration in the proximal Fe
S vibrational frequency. Thus, although Mn-b5 binds to CYP17A1, it is unable 
to enhance the lyase reaction, strongly suggesting that cyt b5 has a redox 
effector role in enhancement of the CYP17A1 mediated lyase reaction 
necessary for androgen synthesis. 
Keywords: CYP17A1, Cytochrome b5, Redox donor, Androgen synthesis, 
Nanodiscs 
Abbreviations 
 Cyt b5, cytochrome b5;  
 Mn-b5, manganese protoporphyrin IX substituted cyt b5;  
 DHEA, dehydroepiandrosterone;  
 PREG, pregnenolone;  
 OH-PREG, 17α-hydroxypregenolone 
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1. Introduction 
The role of cytochrome b5 in P450 mediated metabolism has 
been the subject of intense debate for decades. Although its essential 
role in the fatty acid biosynthetic pathways is well appreciated,1 early 
work with hepatic drug metabolizing enzymes often yielded conflicting 
results. For instance, Sato and coworkers suggested that the binding 
of cytochrome b5 (cyt b5) to cytochrome P450 elicited a structural 
change in the enzyme which activated product turnover, either by 
increasing the inherent catalytic rate or by inhibiting non-productive 
auto-oxidative shunt processes (Fig. 1).2 Alternatively, as cyt b5 
contains a bis-imidazole coordinated heme, direct transfer of electrons 
from cyt b5 to P450 has been proposed.2,3 In this latter role, the 
relatively high redox potential of cyt b5 (∼0 mV versus Normal 
Hydrogen Electrode Ref.4) suggests that electron transfer to ferric 
P450 (redox potential ∼ −300 mV vs. NHE) is unfavorable. Hence it 
was suggested that the redox function of cyt b5 involved electron 
transfer to the ferrous dioxygen intermediate which has a redox 
potential near 0 mV5 thus providing the “second electron” in the 
normal monooxygenase stoichiometry. In an attempt to differentiate 
between these two roles, Coon and co-workers reconstituted apo-cyt 
b5 with manganese protoporphyrin IX.6 They observed no reduced Mn-
b5 in the presence of cytochrome P450 reductase (CPR) and NADPH, 
whereas iron cyt b5 was rapidly reduced. Hence Mn-b5 is incapable of 
any electron transfer to the P450. From their experiments on various 
P450 reactions they concluded that cyt b5 effects depend on the 
specific P450 in question, the substrate being examined, and molar 
ratio of CPR to P450. This suggested that their observations could not 
be explained solely by a simple electron transfer role and some effects 
may also be caused by possible conformational changes caused by cyt 
b5 binding. While the role of cyt b5 in drug metabolism continues to be 
explored, a more interesting and potentially critical function of cyt b5, 
is in human steroid biosynthesis. 
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Fig. 1. Cytochrome P450 reaction cycle. Black arrows represent the path followed for 
CYP17A1 mediated hydroxylation chemistry, while red arrows represent the CYP17A1 
mediated carbon-carbon scission reaction, the lyase chemistry. The first reduction is 
indicated as being carried out by CPR, while the second electron can be donated by 
either CPR or cytochrome b5. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of this article.) 
The synthesis of androgens, estrogens and corticosteroids 
involves multiple P450 catalyzed reactions. Cytochrome P450 17A1 
(CYP17A1) is a key player in these reactions, being responsible for 
catalyzing 17α-hydroxylation of pregnenolone and progesterone 
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followed by C17C20 bond scission in a separate lyase reaction to form 
dehydroepiandrosterone (DHEA) and androstenedione (AD) 
respectively (Fig. 2). The hydroxylation reactions occur throughout a 
person’s lifetime, and when a person approaches adrenarche, the 
hydroxylated products can be shunted towards the subsequent step of 
formation of androgenic precursors by CYP17A1 in addition to the 
production of glucocorticoids.7 The presence of membrane bound form 
of cyt b5 has been known to selectively and significantly enhance the 
rate of the lyase reaction.8 Mutations of CYP17A1 surface residues: 
R347, R358 and K89 which are known to interact with cyt b5, have 
been shown to cause impairment of lyase activity.9 In a recent report, 
significant lyase impairment was shown in mice testicular Leydig cells 
lacking cyt b5.10 Additionally, male patients with mutations causing a 
lack of cyt b5 present with pseudo hermaphroditism, while high cyt b5 
expression in adrenocortical adenomas in Cushing’s syndrome patients 
has been associated with increased androgen synthesis.11 Clearly, cyt 
b5 has a physiological significance in maintaining normal levels of 
androgen synthesis. The nature of this role has been long 
debated,8,12,13,14 with Auchus and coworkers studying lyase activity in 
recombinant yeast using apo b5 which stimulated the lyase reaction, 
leading these workers to conclude that there is no redox role.15 A 
similar report from Akhtar and coworkers mentions unpublished results 
demonstrating lyase enhancement in a reconstituted system utilizing 
Mn-b5.9 On the contrary, Estabrook and others demonstrated in an 
in vitro reconstituted system in the presence of lipids that a zinc 
substituted derivative of b5 did not stimulate the lyase activity of 
CYP17A1, and that the previous reports of rate enhancement by apo b5 
are the result of transfer of the heme group from the P450 to apo b5 
forming the holoenzyme.16 Another property of cyt b5 that complicates 
all previous reports is the need for an intact membrane to influence 
the P450 activity.17 Given the key importance of cyt b5 in the 
regulation of androgen synthesis, it is imperative that this disparity 
about the role of cyt b5 be solved in a reproducible system 
representative of the membrane environment of these proteins. To this 
end, we employ the Nanodisc system to reconstitute CYP17A1, CPR 
and cyt b5 in controlled stoichiometric ratios. We reconstituted cyt b5 
with manganese protoporphyrin IX and investigated the rate of lyase 
reaction by CYP17A1 in Nanodiscs, with iron containing cyt b5, or with 
Mn-protoporphyrin IX substituted form of cyt b5 (Mn-b5) and compared 
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each case versus the rate in the absence of cyt b5. In humans, 
androgens are primarily derived from the 17α-hydroxypregnenolone 
substrate, therefore we decided to investigate this reaction to 
determine whether cyt b5 is a redox donor in CYP17A1 mediated lyase 
reaction for androgen synthesis. Additionally, we probed the ferric 
resting state of CYP17A1 in the presence of native substrates to 
indicate formation of the b5-CYP17A1 complex.  
 
Fig. 2. CYP17A1 catalyzed reactions in steroidogenesis. 
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2. Materials and methods 
2.1. Expression and purification of recombinant 
proteins, Nanodisc assembly 
The expression and purification of CYP17A1 was performed as 
described.18 The expression and purification of membrane scaffold 
protein and cyt b5 were performed as described.19,20 Nanodiscs with 
CYP17A1 were assembled as documented.21 Incorporation of CPR and 
cyt b5 into purified CYP17A1 Nanodiscs was performed by direct 
addition of CPR and/or cyt b5 in 2–4-fold molar excess, as 
documented.22,23,24 
2.2. Reconstitution of cyt b5 with manganese 
protoporphyrin IX 
Cyt b5 was reconstituted with Mn-protoporphyrin IX according 
to,6 with the following changes: After performing buffer exchange with 
G-25 column to separate unbound Mn-protoporphyrin IX, the eluate 
was run through a DEAE-cellulose column, equilibrated with 25 mM 
Tris acetate (pH 8.0), 1 mM EDTA and 10 mM sodium cholate. A linear 
salt gradient was formed using the equilibration buffer supplemented 
with 1 M NaCl. Mn-b5 fractions which were characterized on the basis 
of their observed Rz ratios, were pooled and rigorously dialyzed 
against 100 mM potassium phosphate buffer (pH 7.4) and flash frozen 
in liquid nitrogen before being stored at −80 °C until use. 
2.3. Spectroscopic characterizations of Nanodisc 
incorporated CYP17A1 and of Mn-b5 
Nanodisc incorporated CYP17A1 was characterized by UV–visible 
spectroscopy in a Cary 300 UV–visible spectrophotometer. The amount 
of P450 was determined by change in spin shift upon pregnenolone 
binding using ε390−ε417 = 100 mM−1 cm−1.25 Mn-b5 was quantified using 
UV–visible spectroscopy using ε368 = 50 ± 2 mM−1 cm−1 and 
ε468 = 38 ± 1.5 mM−1 cm−1.6 Purity and identity of all proteins was 
confirmed by denaturing electrophoresis and MALDI-mass 
spectrometry. 
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2.4. Determination of NADPH oxidation rates 
NADPH oxidation rates and product formation rates were 
determined with 365 pmoles of CYP17A1 in Nanodiscs reconstituted 
with 4-fold CPR, with/without the addition of 4-fold cyt b5. The solution 
was brought to 1 mL by the addition of 100 mM potassium phosphate 
buffer (pH 7.4) containing 50 mM NaCl and 50 μM 17α-
hydroxypregnenolone (Sigma) in a stirred quartz cuvette. The solution 
was equilibrated at 37 °C by incubation for 5 min and reaction was 
initiated by addition of NADPH solution. The NADPH consumption was 
monitored by change in absorbance at 340 nm for 15 min and the 
linearity was verified. At 15 min the reaction was quenched by adding 
50 μL 8.9 N sulfuric acid. Each sample was flash frozen in liquid 
nitrogen and stored at −80 °C until product analysis. These reactions 
were performed in a Cary 300 UV–visible spectrophotometer fitted 
with magnetic stirrer and Peltier temperature controller. 
2.5. Determination of product formation rates 
Frozen samples were thawed and extraction of analytes was 
performed as previously documented.23 The product analysis was 
performed by gas chromatography with a DB-17 phenol substituted 
siloxane column and a flame ionization detector on a Hewlett-Packard 
6890 gas chromatograph, and the chromatograms were processed 
with Grams/32 AI software. 
2.6. Preparation of Raman samples 
CYP17A1 incorporated in Nanodiscs in 100 mM potassium 
phosphate buffer (pH 7.4) was concentrated to 200 μM and 2-fold 
excess of Mn-b5 was added from a 400 μM solution in the same buffer. 
The resultant solution incubated at 37 °C for 15 min. Substrate was 
added to each sample from methanolic stocks such that the final 
concentration was 420 μM.24 Finally, ultrapure glycerol was added to a 
concentration of 15% (v/v); i.e., the final concentration of CYP17A1 
was calculated to be 85 μM. The samples were flash frozen in liquid 
nitrogen and stored at −80 °C until analyzed. 
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2.7. Resonance Raman spectroscopy 
To determine the effect of cyt b5 on the heme stretching modes 
in ferric CYP17A1, we employed the Mn reconstituted form of cyt b5. 
This was done to prevent interference from the heme of cyt b5 as was 
done previously by Mak et al. in rR studies on CYP2B4.26,27 We 
acquired resonance Raman spectra after adding 2-fold and 4-fold 
excess of Mn-b5. The high frequency spectra were acquired using the 
406.7 nm excitation line from a Krypton ion laser (Coherent Innova 
Sabre Ion Laser) and changes in the ν(FeS) stretching mode were 
investigated using the 356.4 nm excitation line from the same laser, a 
wavelength known to selectively enhance this mode.28 The RR spectra 
of all samples were measured using a Spex 1269 spectrometer 
equipped with a Spec-10 LN liquid nitrogen-cooled detector (Princeton 
Instruments, NJ). The laser power was adjusted to ∼10 mW at the 
sample. All samples were measured in a spinning NMR tube to avoid 
local heating and protein degradation. The spectra were collected 
using a 180° backscattering geometry, with the laser beam being 
focused as a line image on the sample tube using a cylindrical lens. 
Spectra were calibrated with data acquired for fenchone and processed 
with Grams/32 AI software (Galactic Industries, Salem, NH). 
3. Results 
3.1. Reconstitution and characterization of Mn-b5 
Mn-b5 was successfully reconstituted from a purified preparation 
of apo-cyt b5. The complete reconstitution was confirmed by UV–
visible spectroscopy. SDS-PAGE analysis and MALDI-MS using a 
sinapinic acid matrix confirmed the presence of highly purified and full 
length protein construct of Mn-b5 as well as cyt b5 (data not shown). 
3.2. NADPH oxidation and catalytic turnover of 17α-
hydroxypregnenolone in the presence of cyt b5 or Mn-b5 
The rates of NADPH oxidation and product formation in the 
presence of cyt b5 and Mn-b5 were compared to the rates in the 
absence of any added cyt b5. The presence of cyt b5 increases the 
product formation rate ∼5 fold, while the addition of Mn-b5 does not 
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cause any change (Fig. 3A). The rates of NADPH oxidation were close 
in value in all three cases, 54 ± 1.3 min−1 for cyt b5, 51 ± 1.0 min−1 
for Mn-b5 and 46 ± 1.9 min−1 for reactions in the absence of any b5. 
The efficiency of coupling was calculated as the ratio of product 
formation rate to the rate of NADPH consumption. This was seen to be 
maximal in the reactions with cyt b5, while reactions with no b5 and 
with Mn-b5 had similar coupling efficiency (Fig. 3B). 
 
Fig. 3. Comparison of CYP17A1 catalyzed lyase reactions with 17α-hydroxy-
pregnenolone as substrate, with no cytochrome b5 present, or with Mn-b5, or native 
cytochrome b5. (A) DHEA product formation rates (B) Coupling efficiencies (calculated 
as the percent ratio of amount of product formed to the amount of NADPH consumed). 
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3.3. Resonance Raman spectroscopy on Mn-b5 binding 
to ferric CYP17A1 
As was reported in an earlier work,29 binding of pregnenolone to 
substrate-free CYP17A1 causes a spin state conversion from almost 
pure low spin (LS) to largely high spin (HS) form, while binding of 
17α-hydroxypregnenolone generates a lower HS fraction. The 
persistence of more LS component being attributed to the tendency of 
the 17α-hydroxy fragment of the substrate to directly interact with the 
heme iron or promote retention of distal pocket water molecules. In 
the present work, additions of Mn-b5 to substrate-bound forms of 
CYP17A1, creating 2-fold excesses relative to the enzyme, cause 
relatively small increases of the LS component in these samples. This 
is reflected in the resonance Raman (rR) spectra illustrated in Fig. 4 
for the samples bearing a 2-fold excess of Mn-b5. As can be seen in 
trace B, pregnenolone bound CYP17A1 interacting with Mn-b5 shows a 
spectrum similar to that for the sample without Mn-b5 (trace A); they 
both exhibit a strong isolated ν3 mode at 1488 cm−1 and a small signal 
for LS population near 1500 cm−1. Employing a procedure developed in 
our laboratory by Mak et al.,30 it is possible to estimate the spin state 
population using the intensity ratio of IHS/ILS equal to 1.24. Using this 
value, the HS population of pregnenolone bound CYP17A1 in the 
presence of a 2-fold excess of Mn-b5 is calculated to be 80%, close to 
the value observed in the absence of Mn-b5. Similarly, it is noted that 
the HS component changes from ∼57% to ∼50% when a 2-fold excess 
of Mn-b5 was added into 17α-hydroxypregnenolone bound CYP17A1 
(Fig. 4 right panel, trace D). These remained nearly the same even in 
the presence of 4-fold Mn-b5, indicating that all of CYP17A1 binding 
sites for cyt b5 have been occupied (data not shown). In addition to 
the relatively minor effects on spin state populations, as can be seen 
in Fig. 4, it is important to emphasize that the frequencies observed 
for both the low energy and high energy internal modes of the heme 
prosthetic group do not shift relative to those observed for the 
corresponding samples without Mn-b5, implying that the interaction 
with Mn-b5 does not induce significant structural changes of the heme 
macrocycle or its peripheral substituents in the substrate-bound ferric 
enzyme. Though minimal effects were observed for spin state 
populations and heme structure, it is noted that association of 
CYP17A1 with Mn-b5 increases the strength of Fe S linkage, 
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demonstrating the formation of a CYP17A1:Mn-b5 complex. This is 
evident from viewing the inserts for the low-frequency spectra in 
Fig. 4, where the ν(Fe S) stretching modes occurring in samples with 
the excess Mn-b5 appear at 350 cm−1, while those previously reported 
for the same samples of CYP17A1 in Nanodiscs without Mn-b5 appear 
at 347 cm−1.29 
 
Fig. 4. Resonance Raman Spectra of CYP17A1 ± Mn-b5. The right panel shows the 
high-frequency region of the acquired spectra, while the left panel shows the low 
frequency region; the spectra were acquired using the 406.7 nm excitation line from a 
Krypton ion laser, noting that the inset bands in the low frequency region were 
acquired with the 356.4 nm excitation line from the same laser, a wavelength that 
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selectively enhances the ν(Fe S) stretching mode.28 Spectra traces in B and D are 
the resulting traces after subtraction of spectra obtained for samples containing the 
equivalent concentration of Mn-b5. 
4. Discussion 
CYP17A1 is a critical enzyme in steroidogenesis, lying at the 
branch point of glucocorticoids synthesis and androgen synthesis. It 
performs hydroxylation on the pregnene-nucleus to form hydroxylated 
products which can either be diverted to glucocorticoid synthesis, or 
undergo a C C bond lyase reaction by CYP17A1 to produce 
androgens. Cytochrome b5 is known to be the chief regulator of 
CYP17A1 reactivities in vivo, yet the nature of interactions of CYP17A1 
with cyt b5 is not clearly understood. Cyt b5 is known to enhance the 
lyase reactions from 5 to 10 fold. Whether cyt b5 acts as an allosteric 
modulator or if it functions as a second electron donor has long been 
debated,15,16 and conflicting reports from various groups are 
complicated by the fact that these studies were carried out in 
uncontrolled conditions where aggregation states and stoichiometries 
of interactions were not known.15,31,32 Scott and coworkers have used 
solution NMR with soluble forms of the proteins to study the 
conformational changes occurring in CYP17A1 bound to lyase 
substrates upon cyt b5 binding and associated them with an allosteric 
role for cyt b5,12,33 although not directly addressing a possible redox 
role. The application of Nanodisc technology to this system is therefore 
an effective solution, enabling us to study reactions in controlled 
stoichiometries in a native-like membrane environment. 
We reconstituted cyt b5 with Mn-protoporphyrin IX, which is 
known to be redox inactive under these conditions,6 and tested the 
rate of lyase reaction in 17α-hydroxypregnenolone in the presence and 
absence of cyt b5, and also in the presence of Mn-b5. Reactions with 
Mn-b5 showed no enhancement of the rate of DHEA formation, which 
suggests very strongly that cyt b5 has a definite redox donor role in 
the CYP17A1 lyase chemistry. Importantly, presence of cyt b5 
increases the coupling efficiency about 5-fold. Given the relatively high 
redox potential of cyt b5 (∼0 mV NHE),4 its redox role is limited to 
reduction of the oxy-complex,5 giving rise to the nucleophilic peroxo-
species, the reactive intermediate responsible for carbon-carbon bond 
scission.23,34 An enhanced reduction rate of the oxy-complex is 
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expected to increase the steady-state concentration of the 
peroxoanion, which in the absence of cyt b5 is depleted through non-
productive release of hydrogen peroxide. Our resonance Raman data 
with Mn-b5 binding to ferric CYP17A1 indicate no major structural 
changes of the heme planar modes, whereas on the proximal side, Fe
S bond was observed to get strengthened when Mn-b5 was bound. 
Clearly, Mn-b5 binds to CYP17A1, but is incapable of enhancing the 
lyase activity, the latter being enhanced if the native iron containing 
cyt b5 is bound. Taken together, these experiments provide strong 
evidence that cyt b5 is serving as a redox partner in CYP17A1 catalytic 
cycle, most likely delivering a second electron to the oxy-complex and 
facilitating formation of the peroxo-ferric complex, which recent 
evidence shows to be the catalytically active intermediate in the lyase 
reaction.34 This result is in agreement with conclusions on the role of 
cyt b5 in CYP2B4 catalysis.14,35 Although our results cannot disprove 
the presence of functionally important allosteric interactions between 
cyt b5 and CYP17A1, the lack of any effect of Mn-b5 on the rate of 
turnover of 17α-hydroxypregnenolone, as compared with 5-fold 
acceleration of this reaction in the presence of cyt b5, suggests that 
these allosteric interactions do not play significant role in the human 
CYP17A1 mediated catalysis of lyase reaction. 
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